BVMF/A2RR34 (BVMF/A2RR34)

Brazil Stock Exchange: BVMF/A2RR34 · BRL

R$39.8

+3.48 (+9.6%)· Recorded snapshot

Market cap	45.7B
Revenue (ttm)	3.5B
Net income (ttm)	-1.7B
EPS (ttm)	-R$1.54
Volume	55
Beta	1.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.5B
Net income (ttm): -1.7B
EPS (ttm): -R$1.54
Market cap: 45.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11.9P50 16.6P75 25.6

Trailing P/En/a

P25 15.1P50 22.9P75 38.5

ROE-55.2

P25 2.7P50 10.8P75 20.1

ROIC-101.1

P25 6.3P50 12.1P75 21.3

Benchmarks · 1M

All BVMF/A2RR34 indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-25
Employees	711
Employees change	102
Employees growth	16.75%
Enterprise value	BRL 44.5B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	2003
Industry	Biotechnology
Is primary listing	No
ISIN number	BRA2RRBDR009
Last earnings date	2026-08-04
Last refreshed	2026-10-29
Market cap	BRL 45.7B
Next earnings date	2026-11-25
Price	BRL 39.76
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bvmf/A2RR34
Website	https://arrowheadpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-3.86%
EV/Sales	12.38x
FCF / EV yield	-0.87%
FCF yield	-0.85%
P/B ratio	18.93x
P/S ratio	13.17x
Price / tangible book value	19.18x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-33.82%
EBITDA margin	-29.97%
Gross margin	100%
Operating margin	-33.82%
Pretax margin	-37.65%
Profit margin	-47.79%
Profit per employee	BRL -2.3M
Revenue per employee	BRL 4.9M
ROA	-8.1%
ROA (5Y)	-16.64%
ROCE	-12.38%
ROE	-55.21%
ROE (5Y)	-76.13%
ROIC	-101.07%
ROIC (5Y)	-116.09%
SBC / revenue	10.46%
Tax / revenue	2.99%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	16.85%
Gross profit growth (Q)	171.02%
Gross profit growth 3Y	37.74%
Gross profit growth 5Y	44.13%
Net income growth years	1
Revenue growth	16.85%
Revenue growth (Q)	171.02%
Revenue growth (QoQ)	2.06%
Revenue growth 10Y	128.73%
Revenue growth 3Y	37.74%
Revenue growth 5Y	44.13%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -83.2M
Depreciation and amortization	BRL 138.8M
EBIT	BRL -1.2B
EBITDA	BRL -1B
EPS	BRL -1.54
Financing cash flow	BRL 4.1B
Free cash flow	BRL -389.1M
Free cash flow minus SBC	BRL -751.8M
Gross profit	BRL 3.5B
Income taxes	BRL 103.9M
Investing cash flow	BRL -4.2B
Net borrowing	BRL 3.1B
Net cash flow	BRL -388.7M
Net income	BRL -1.7B
Operating cash flow minus SBC	BRL -668.6M
Operating income	BRL -1.2B
Revenue	BRL 3.5B
Stock-based compensation	BRL 362.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.1
Book value per share	BRL 17.09
Debt / equity	2.96
Interest coverage	-2.45
Long-term assets	BRL 2B
Long-term liabilities	BRL 7B
Net cash (debt)	BRL 1.1B
Net cash / market cap	2.48%
Net cash growth	22.88%
Net debt / equity	-0.47
Piotroski F-Score	2
Property, plant and equipment	BRL 2.3B
Shareholders' equity	BRL 2.4B
Tangible book value	BRL 2.4B
Tangible book value per share	BRL 16.88
Total assets	BRL 10.9B
Total cash	BRL 8.3B
Total debt	BRL 7.1B
Total liabilities	BRL 8.5B
WACC	10.59%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.38
Current assets	BRL 9B
Current liabilities	BRL 1.5B
Current ratio	5.9
Net working capital	BRL -835.5M
Quick ratio	5.71
Working capital	BRL 7.2B
Working capital turnover	3.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.74%
Shareholder yield	-7.74%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 46.33
1D price change	9.59%
1M price change	-13.19%
1M total return	-13.19%
1W price change	10.44%
1W total return	10.44%
1Y price change	57.59%
1Y return CAGR	57.64%
1Y total return	57.59%
20-day SMA	BRL 39.70
200-day SMA	BRL 45.48
3M price change	-26.51%
3M total return	-26.51%
3Y price change	146.8%
3Y return CAGR	35.13%
3Y total return	146.8%
50-day SMA	BRL 48.47
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 59.95
52-week high date	2026-07-22
52-week low	BRL 25.26
52-week low date	2025-11-07
6M price change	-14.16%
6M total return	-14.16%
All-time high	BRL 59.95
All-time high date	2026-07-22
All-time low	BRL 7.24
All-time low date	2025-04-07
Average true range (ATR)	BRL 1.26
Average volume	433.8
Beta (5Y)	1.3
Change from 52-week high	-33.68%
Change from 52-week low	57.4%
Change from all-time high	-33.68%
Change from all-time low	449.17%
Change from open	0%
Day's gap	9.59%
Dollar volume	BRL 2,187
High price	BRL 39.76
Low price	BRL 39.76
Monthly RSI	55.78
Open price	BRL 39.76
Previous close	BRL 36.28
Price vs 150-day SMA	-14.19%
Price vs 20-day SMA	0.16%
Price vs 200-day SMA	-12.57%
Price vs 50-day SMA	-17.97%
Relative volume	0.13
RSI	43.62
Sharpe ratio	1.7
Sortino ratio	3.08
Volume	55
Weekly RSI	43.59
YTD price change	-12.81%
YTD total return	-12.81%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	122.4M
Shares change (QoQ)	0.67%
Shares change (YoY)	7.74%
Shares held by insiders	3.32%
Shares held by institutions	77.65%
Short ratio	6.3 days

Deeper analysis on BVMF/A2RR34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/A2RR34 report

Is a complete BVMF/A2RR34 research report available?

No complete published report is available for bvmf/A2RR34 (BVMF/A2RR34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/A2RR34 (BVMF/A2RR34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/A2RR34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/A2RR34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/A2RR34

Frequently asked questions